| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |